References
1. BETADINE® 2.5% Dry Powder Spray Local Package Insert Leaflet
2. Mayer DA, et al. Povidone-Iodine and wound healing: A Critical Review. Wounds: A Compendium of Clinical Research and Practice. 1993; 5(1): 14-23.
3. Remington “The Science & Practice of Pharmacy” 20th Ed, William K.Nichols, PhD. Anti-Infectives. Chapter 87-1516
4. Fleischer W, Reimer K. Povidone Iodine: in antisepsis-State of Art. Dermatology 1997;195 (suppl 2):3-9
5. Saggers BA, Stewart GT. Polyvinyl-pyrrolidone-iodine: an assessment of antibacterial activity. J Hyg. 1964; 62: 509-518
6. Plotkin SA. Medical and Surgical Antisepsis with BETADINE®. Microbicides. New York;The Purdue Frederick Company. 1972:9-16 .
7. Reimer K, Schreier H, Erdos G, Konig W, Fleischer W. Molecular effects of a microbicidal substance on relevant microorganisms: electron microscopic and biochemical studies on Povidone-iodine. Zentralbi Hyg Umweltmed. 1998 Feb; 200(5-6):423-34.
8. Russel, AD. Similarities and differences in the responses of microorganisms to biocides. J Antimicrobiol Chemo (2003) 52, 750-763.
9. Rutala W, Weber D. The Healthcare Infection Control Practices Advisory Committee (HICPAC)
10. Mcdonnell G, Russell AD. Antiseptics and disinfectants: activity, action and resistance. Clin Microbiol Rev. Jan. 1999. 147-179.
11. Eming SA, et al. A novel property of povidone-iodine: inhibition of excessive protease levels in chronic non-healing wounds. J In Dermatol (2006) 126, 2731-2733.
12. Kunisada T,Yamada K, Oda S and Hara O. Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology 1997; 195(suppl 2): 14-18.
13. Lachapelle J, Castel O, et al. Antiseptics in the era of bacterial resistance: a focus on povidone iodine. Clin. Pract. (2013) 10(5), 579-592.
14. Hand, Foot and Mouth Disease Information Sheet. World Health Organization (Western Pacific Region). Available at http://www.wpro.who.int/emerging_diseases/hfmd.information.sheet/en. Accessed on 29/11/2016.
15. Leyden J., Stewart R., et al. Updated in vivo Methods for Evaluating Topical Antimicrobial Agents on Human Skin. The Journal of Investigative Dermatology, Vol 72(4): 165-170, 1979
Please report any suspected Mundipharma Product or Device related adverse event or product complaint to: meadrugsafety@mundipharma.ae or contact +971 4 439 8777.
Consult your doctor / pharmacist before taking pharmaceutical products